Singapore markets closed

AnaptysBio, Inc. (ANAB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
26.58+0.24 (+0.91%)
At close: 04:00PM EDT
26.75 +0.17 (+0.64%)
After hours: 04:03PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-163,619
-163,619
-128,724
-57,796
-19,931
Depreciation & amortisation
2,376
2,376
2,335
2,090
1,617
Stock-based compensation
33,205
33,205
27,356
15,347
11,499
Change in working capital
-324
-324
6,839
-7,489
-7,829
Accounts receivable
-5,432
-5,432
-543
-876
0
Accounts payable
10,938
10,938
9,700
-4,740
-7,694
Other working capital
-121,607
-121,607
-73,951
-47,286
-14,726
Other non-cash items
676
18,083
21,108
1,450
-
Net cash provided by operating activities
-120,800
-120,800
-73,593
-45,920
-14,157
Cash flows from investing activities
Investments in property, plant and equipment
-807
-807
-358
-1,366
-569
Purchases of investments
-303,919
-303,919
-802,503
-118,662
-194,927
Sales/maturities of investments
449,480
449,480
408,016
158,848
289,971
Net cash used for investing activities
144,754
144,754
-394,845
38,835
94,475
Cash flows from financing activities
Debt repayment
-
-
0
0
-1,375
Common stock issued
2,472
2,472
11,827
2,553
496
Common stock repurchased
-50,000
-50,000
0
0
-
Other financing activities
-11,769
-11,769
32,190
249,745
-
Net cash used provided by (used for) financing activities
-59,297
-59,297
44,017
252,298
-879
Net change in cash
-35,343
-35,343
-424,421
245,213
79,439
Cash at beginning of period
71,308
71,308
495,729
250,516
171,077
Cash at end of period
35,965
35,965
71,308
495,729
250,516
Free cash flow
Operating cash flow
-120,800
-120,800
-73,593
-45,920
-14,157
Capital expenditure
-807
-807
-358
-1,366
-569
Free cash flow
-121,607
-121,607
-73,951
-47,286
-14,726